Brain Cancer Research: Can A Combination Come Into Play?
Brain cancer research seems to place a great amount of focus on glioblastoma and it's not hard to see why. To many, it is the kind of condition that those in this particular field are able to focus on, seeing as how it is one of the more detrimental ones from a medical standpoint. That being said, is it possible that combination of drugs can come into great effect in the long term? I believe this to be especially true, as this ailment has impacted a number of patients.
US News and World Report posted an article about a potential treatment that could prove useful for the sake of treating glioblastoma. This is one point that should be looked into but you have to keep in mind that this condition stands as one of the most aggressive and common conditions seen in the brain. According to a study that was done by the University of Zurich, it is "virtually incurable." That being said, it seems like a two-pronged drug therapy approach could prove useful in the long term.
The study group put together a procedure that would be able to target the tumors that were seen in mice. They were simultaneously injected with a T cell-boosting protein referred to as interleukin-12, as well as another drug that would serve to block an inhibitory function within the T cell. In spite of only IL-12 being put to use, there was an increased survival rate in mice by 25%. While this is a notable result to consider, is it possible that it can only stop at this point?
I believe that this is a particular case that will be able to benefit the ongoings that are associated with brain cancer research. Another drug would be able to come into play, making sure that the T cells could not regulate like they would have normally. The survival rate, in turn, changed from 25% and boosted to a much higher 80%. To say that this type of increase is tremendous would be an understatement and I'd like to think that many organizations would be able to focus on it, V-A-B-C seen amongst them.
I think that, regardless of where this type of news goes, it's apparent that there are possibilities which exist. I believe that brain cancer research is all about finding out what works best and sticking with it or searching to find entirely unique drugs that can work alone or with others. The tandem that was referred to before is, in my mind, quite noteworthy. I have to believe that, in time, this will be able to develop and go on to become utilized in studies to come.
US News and World Report posted an article about a potential treatment that could prove useful for the sake of treating glioblastoma. This is one point that should be looked into but you have to keep in mind that this condition stands as one of the most aggressive and common conditions seen in the brain. According to a study that was done by the University of Zurich, it is "virtually incurable." That being said, it seems like a two-pronged drug therapy approach could prove useful in the long term.
The study group put together a procedure that would be able to target the tumors that were seen in mice. They were simultaneously injected with a T cell-boosting protein referred to as interleukin-12, as well as another drug that would serve to block an inhibitory function within the T cell. In spite of only IL-12 being put to use, there was an increased survival rate in mice by 25%. While this is a notable result to consider, is it possible that it can only stop at this point?
I believe that this is a particular case that will be able to benefit the ongoings that are associated with brain cancer research. Another drug would be able to come into play, making sure that the T cells could not regulate like they would have normally. The survival rate, in turn, changed from 25% and boosted to a much higher 80%. To say that this type of increase is tremendous would be an understatement and I'd like to think that many organizations would be able to focus on it, V-A-B-C seen amongst them.
I think that, regardless of where this type of news goes, it's apparent that there are possibilities which exist. I believe that brain cancer research is all about finding out what works best and sticking with it or searching to find entirely unique drugs that can work alone or with others. The tandem that was referred to before is, in my mind, quite noteworthy. I have to believe that, in time, this will be able to develop and go on to become utilized in studies to come.
About the Author:
Visit Voices Against Brain Cancer if you are looking for some more information about brain cancer awareness and research.. This article, Brain Cancer Research: Can A Combination Come Into Play? is available for free reprint.